3rd Quarter - Report

PURDUE PHARMA, LP for PURDUE PHARMA LP

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)

LobbyistCovered position, as disclosed
BURT E ROSEN n/a

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), S. 660 (111th), H.R. 756 (111th), H.R. 1427 (111th), S. 301 (111th), S. 1292 (111th), S. 515 (111th), S. 610 (111th), S. 1336 (111th), H.R. 3962 (111th), H.R. 1260 (111th), S. 726 (111th), H.R. 1298 (111th), H.R. 5809 (111th), H.R. 3200 (111th), S. 1796 (111th), H.R. 1706 (111th), S. 369 (111th), H.R. 5712 (111th), H.R. 1359 (111th), H.R. 3590 (111th), H.R. 4872 (111th), H.R. 1191 (111th), S. 525 (111th), H.R. 6165 (111th), H.R. 4956 (111th)

Copyright/Patent/Trademark CPT

H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)

LobbyistCovered position, as disclosed
BURT E ROSEN n/a

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3962 (111th), H.R. 3590 (111th), H.R. 1298 (111th), H.R. 5712 (111th), H.R. 1191 (111th), H.R. 1427 (111th), S. 1292 (111th), S. 1796 (111th), H.R. 1359 (111th), H.R. 5809 (111th), H.R. 756 (111th), S. 525 (111th), S. 660 (111th), H.R. 1548 (111th), S. 610 (111th), H.R. 4956 (111th), H.R. 1706 (111th), S. 301 (111th), S. 1336 (111th), H.R. 4872 (111th), S. 726 (111th), H.R. 3200 (111th), H.R. 1260 (111th), S. 515 (111th), H.R. 6165 (111th), S. 369 (111th)

Health Issues HCR

H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)

LobbyistCovered position, as disclosed
BURT E ROSEN n/a

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 369 (111th), H.R. 1706 (111th), H.R. 4956 (111th), S. 301 (111th), H.R. 756 (111th), H.R. 1359 (111th), H.R. 1298 (111th), H.R. 6165 (111th), S. 1336 (111th), H.R. 3962 (111th), S. 726 (111th), S. 610 (111th), S. 525 (111th), H.R. 3590 (111th), S. 1292 (111th), S. 515 (111th), H.R. 1260 (111th), H.R. 1427 (111th), S. 660 (111th), H.R. 4872 (111th), S. 1796 (111th), H.R. 5712 (111th), H.R. 5809 (111th), H.R. 3200 (111th), H.R. 1548 (111th), H.R. 1191 (111th)

Medicare/Medicaid MMM

H.R.756/S.660 National Pain Care Policy Act of 2009 H.R.1191/S. 1336 Safe Drug Disposal Act of 2009 H.R.1260/S.515/S.610 Patent Reform Act of 2009 H.R.1298/S.525 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.1359/S.1292 Secure and Responsible Drug Disposal Act of 2009 H.R.1427/S.726 Promoting Innovation and Access to Life-Saving Medicine Act H.R.1548 Pathway for Biosimilars Act H.R.1706 Protecting Consumer Access to Generic Drugs Act of 2009 H.R.3200 America's Affordable Health Choices Act of 2009 H.R.3590 Patient Protection and Affordable Care Act H.R.3962 Affordable Health Care for America Act H.R.4872 Health Care and Education Reconciliation Act of 2010 H.R.4956 Stop Oxy Abuse Act of 2010 H.R.5712 VeteranS', Seniors', and Children's Health Technical Corrections Act of 2010 H.R.5809/S.3397Safe Drug Disposal/Secure and Responsible Drug Disposal Act of 2010 H.R.6165 Life Sciences Jobs and Investment Act of 2010 S.301 Physician Payments Sunshine Act of 2009 S.369 Preserve Access to Affordable Generics Act of 2009 S.1796 America's Healthy Future Act of 2009 Anti- counterfeiting legislation concerning drugs (pedigree) Biosimilar Drugs Disposal of Drugs Drug Reimportation Healthcare Reform Hearings related to prescription drug abuse and prevention Life sciences research tax credit legislation Patent Settlements Pedigree Legislation Prescription Drug User Fee Act reauthorization RiskEvaluation and MitigationStrategies for controlled substances Tax on pharmaceutical companies (Senate Finance Committee draft of health care reform)

LobbyistCovered position, as disclosed
BURT E ROSEN n/a

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1427 (111th), H.R. 1706 (111th), S. 515 (111th), H.R. 1191 (111th), H.R. 5809 (111th), S. 369 (111th), H.R. 4872 (111th), S. 525 (111th), H.R. 3962 (111th), S. 1796 (111th), S. 726 (111th), H.R. 6165 (111th), H.R. 1260 (111th), H.R. 5712 (111th), H.R. 756 (111th), H.R. 4956 (111th), S. 660 (111th), H.R. 3590 (111th), H.R. 1359 (111th), H.R. 1548 (111th), S. 1336 (111th), S. 301 (111th), S. 610 (111th), H.R. 1298 (111th), H.R. 3200 (111th), S. 1292 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.